Phase 2
Completed N=568
Efficacy and Safety of Bromfenac Ophthalmic Solution
Cataract Surgery
Source: ClinicalTrials.gov NCT00585975 ↗
Enrolled (actual)
568
Serious AEs
0.9%
Results posted
Dec 2011
Primary outcomePrimary: Number of Participants With Summed Ocular Inflammation Score (SOIS) of Zero — 157; 164 Participant
Summary
This is a safety and efficacy study of bromfenac ophthalmic solution
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Summed Ocular Inflammation Score (SOIS) of Zero |
157; 164 | — |
| SECONDARY Number of Participants That Are Pain Free |
221; 235 | — |
Eligibility Criteria
Inclusion Criteria
- Male or female greater than or equal to 18 years of age, and scheduled for cataract surgery
Exclusion Criteria
- Active corneal pathology in either eye
Data sourced from ClinicalTrials.gov (NCT00585975). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.